Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
bondholders together with the opinions of the bondholder representative. The bondholders are, therefore, encouraged to thoroughly review the information and exercise their rights to protect their own
with the opinions of the bondholder representative. The bondholders are, therefore, encouraged to thoroughly review the information and exercise their rights to protect their own interests. They should
review the information and exercise their rights to protect their own interests. They should also make necessary inquiries to the bondholders’ representative to obtain comprehensive information before
, therefore, encouraged to thoroughly review the information and exercise their rights to protect their own interests. They should also make necessary inquiries to the bondholder representative to obtain
general shareholders’ meeting on 23 February 2024 and exercise their voting rights on a proposed capital increase to be offered to the existing shareholders in proportion to their shareholding (rights
Rights After Adjustment of Rights Exercise Price 13.3333 per share 13.3333 per share Exercise Ratio 1 unit to 1.5 ordinary shares 1 unit to 1 ordinary shares Number of Warrants (number after the first
income from these projects in the second quarter onward as well. 3.2 Sales and service income from concrete products manufacturing and others in the first quarter of 2019 has increased when compared to the
share 13.333 per share Exercise Ratio 1 unit to 1.5 ordinary shares 1 unit to 1 ordinary shares Number of Warrants (number after the first Exercise on 15 Novmber,2018) 406,573,990 units 609,860,985 units